NeuroPred-GMC: a dual-branch deep learning architecture for neuropeptide prediction based on gated dilated convolutional network and multi-scale convolutional network
Clinical Snapshot
PICO Framework
| P — Population | Protein sequences from neuropeptide and non-neuropeptide datasets |
| I — Intervention | NeuroPred-GMC dual-branch deep learning architecture combining gated dilated convolutional network with ESM-2 features and multi-scale convolutional network with Prot-T5 features |
| C — Comparator | Not clearly specified - appears to be comparison with existing computational prediction methods |
| O — Outcomes | Binary classification performance metrics: accuracy, sensitivity, specificity, precision, MCC, and auROC for neuropeptide prediction |
Bottom Line
NeuroPred-GMC represents a promising computational advancement in neuropeptide prediction, achieving impressive performance metrics (93.24% accuracy, 0.9667 auROC) through innovative dual-branch deep learning architecture. The method combines gated dilated convolutions with multi-scale approaches, leveraging cutting-edge protein language models. While the high performance suggests potential utility in accelerating drug discovery for neurological conditions, the study lacks crucial methodological details, statistical validation, and comparative analysis with existing methods. The open-source availability enhances reproducibility, but clinicians should await peer validation and integration into established drug discovery pipelines before considering this as a reliable screening tool. The computational approach shows promise for identifying novel therapeutic targets in pain management, anxiety disorders, and metabolic conditions, potentially reducing the time and cost of traditional experimental screening methods.
Key Findings
P Value: Not reported
Effect Size: Accuracy: 93.24%, Sensitivity: 93.69%, Specificity: 92.79%
Primary Outcome: Binary classification of neuropeptides vs non-neuropeptides
Nnt Or Sensitivity: Sensitivity: 93.69%, Specificity: 92.79%, auROC: 0.9667
Confidence Interval: Not reported
Clinical Application
High feasibility as computational tool requiring only protein sequence input Relevant to Australian pharmaceutical research and TGA drug development pathways; could support local biotech companies in neuropeptide drug discovery aligned with NHMRC research priorities Researchers in drug discovery, particularly those targeting neurological and psychiatric conditions
Abstract
Neuropeptides are multifunctional signaling molecules in the nervous system. By modulating synaptic transmission and integrating physiological systems, they influence a broad range of functions from pain perception to emotional regulation. Predicting neuropeptides can rapidly expand the library of potential therapeutic targets, thereby providing novel candidate molecules for drug development in areas such as analgesics, anti-anxiety medications, and weight-loss drugs. Traditional experimental methods are extremely time-consuming, labor-intensive, these promising alternative computational methods have emerged. In this study, a dual-branch deep learning architecture for neuropeptide prediction known as NeuroPred-GMC are built up based on gated dilated convolutional network with ESM-2 feature representation and multi-scale convolutional network with Prot-T5 feature representation. Dilated convolution exponentially enlarges the receptive field via increased dilation rates, gating mechanism enables dynamic, selective feature enhancement and noise suppression, and multi-scale convolution captures multi-level contextual information. On the independence test set, the accuracy of 93.24%, Sn of 93.69%, Sp of 92.79%, Pre of 92.86%, MCC of 0.8649 and the auROC of 0.9667 are obtained. The experimental results through cross-validation and independent test demonstrate that the proposed model has good robustness and generalizability, and can serve as a supplemental candidate predictor. The source datasets and codes can be freely available at https://github.com/yunyunliang88/NeuroPred-GMC .
References
- 1.Liang, Y., & Cao, M. (2026). NeuroPred-GMC: a dual-branch deep learning architecture for neuropeptide prediction based on gated dilated convolutional network and multi-scale convolutional network. Journal of Computer-Aided Molecular Design. https://doi.org/10.1007/s12539-025-00761-z
Related Research
Current opinion in chemical biology
Prediction of protein-protein interactions and co-complex models with deep learning
3 Aug 2026
Journal of chemical information and modeling
ProphDR: An Interpretable Deep Learning Model for Predicting Cancer Drug Response via Multi-Omics and Cross-Attention Mechanisms
28 July 2026
PloS one
Multi-view graph-regularized deep metric subspace clustering network
26 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service